{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:50:07Z","timestamp":1774533007958,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.pharma.2016.05.001","type":"journal-article","created":{"date-parts":[[2016,6,11]],"date-time":"2016-06-11T06:37:35Z","timestamp":1465627055000},"page":"54-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Association entre syndrome m\u00e9tabolique et hyperhomocyst\u00e9in\u00e9mie dans une population alg\u00e9rienne"],"prefix":"10.1016","volume":"75","author":[{"given":"M.","family":"Zendjabil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Abbou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Chellouai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.pharma.2016.05.001_bib0105","first-page":"174","article-title":"Syndrome m\u00e9tabolique\u00a0: d\u00e9finitions et \u00e9pid\u00e9miologie","volume":"2","author":"Raoux","year":"2006","journal-title":"Mt Cardio"},{"issue":"9468","key":"10.1016\/j.pharma.2016.05.001_bib0110","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The metabolic syndrome","volume":"365","author":"Eckel","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.pharma.2016.05.001_bib0115","first-page":"30","article-title":"Homocyst\u00e9ine et ath\u00e9roscl\u00e9rose chez les insuffisants r\u00e9naux chroniques","volume":"396","author":"Cherifi","year":"2007","journal-title":"Rev Fr Lab"},{"key":"10.1016\/j.pharma.2016.05.001_bib0120","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome \u2013 a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.pharma.2016.05.001_bib0125","first-page":"581","article-title":"Performances analytiques d\u2019un nouveau dosage de l\u2019estradiol pour l\u2019Advia-Centaur (Siemens): \u00e9valuation clinique dans le cadre de l\u2019assistance m\u00e9dicale \u00e0 la procr\u00e9ation","volume":"70","author":"Lachgar","year":"2012","journal-title":"Ann Biol Clin"},{"issue":"6","key":"10.1016\/j.pharma.2016.05.001_bib0130","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1309\/AJCP64BJIPNPSQDJ","article-title":"Performance characteristics of six homocysteine assays","volume":"130","author":"La\u2019ulu","year":"2008","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.pharma.2016.05.001_bib0135","first-page":"244","article-title":"Relation entre l\u2019homocyst\u00e9ine et la cr\u00e9atinine sanguines chez des sujets atteints de syndrome m\u00e9tabolique et association entre l\u2019hyperhomocyst\u00e9in\u00e9mie et le syndrome m\u00e9tabolique","volume":"26","author":"Ferjani","year":"2011","journal-title":"Immunoanal Biol Special"},{"issue":"1","key":"10.1016\/j.pharma.2016.05.001_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07315724.2010.10719810","article-title":"Age, homocysteine, and oxidative stress: relation to hypertension and type\u00a02\u00a0diabetes mellitus","volume":"29","author":"Dominguez","year":"2010","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.pharma.2016.05.001_bib0145","first-page":"hpu248","article-title":"Elevated homocysteine levels are associated with the metabolic syndrome and cardiovascular events in hypertensive patients","author":"Catena","year":"2014","journal-title":"Am J Hypertens"},{"issue":"4","key":"10.1016\/j.pharma.2016.05.001_bib0150","first-page":"290","article-title":"Homocysteine and metabolic syndrome: from clustering to additional utility in prediction of coronary heart disease","volume":"64","author":"Esteghamati","year":"2014","journal-title":"J Card"},{"issue":"1","key":"10.1016\/j.pharma.2016.05.001_bib0155","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3109\/13813455.2012.735245","article-title":"Relationship of fasting total homocysteine, high sensitivity C-reactive protein and features of the metabolic syndrome in Trinidadian subjects","volume":"119","author":"Nayak","year":"2013","journal-title":"Arch Physiol Biochem"},{"issue":"1","key":"10.1016\/j.pharma.2016.05.001_bib0160","first-page":"56","article-title":"The impact of metabolic syndrome, homocysteine, and B\u00a0vitamins on carotid artery intima-media thickness in hypertensive patients","volume":"29","author":"Liu","year":"2013","journal-title":"Acta Cardiol Sin"},{"issue":"3","key":"10.1016\/j.pharma.2016.05.001_bib0165","first-page":"169","article-title":"Homocyst\u00e9ine et param\u00e8tres du syndrome m\u00e9tabolique et du risque cardiovasculaire chez 2045\u00a0militaires\u00a0: \u00e9tude EPIMIL","volume":"20","author":"Chellak","year":"2005","journal-title":"Immunoanal Biol Special"},{"key":"10.1016\/j.pharma.2016.05.001_bib0170","doi-asserted-by":"crossref","first-page":"A107","DOI":"10.1016\/S1262-3636(13)72080-9","article-title":"Syndrome m\u00e9tabolique et homocysteine","volume":"39","author":"Lakhoua","year":"2013","journal-title":"Diabetes Metab"},{"issue":"2","key":"10.1016\/j.pharma.2016.05.001_bib0175","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1586\/17512433.2015.1010516","article-title":"Homocysteine and the pathogenesis of atherosclerosis","volume":"8","author":"McCully","year":"2015","journal-title":"Exp Rev Clin Pharmacol"},{"key":"10.1016\/j.pharma.2016.05.001_bib0180","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/9781118828533.ch5","article-title":"Homocysteine","author":"Dayal","year":"2015","journal-title":"Atheroscler Risks Mech Ther"},{"key":"10.1016\/j.pharma.2016.05.001_bib0185","first-page":"32","article-title":"Association between serum homocysteine and arterial stiffness in elderly: a community-based study","volume":"11","author":"Zhang","year":"2014","journal-title":"J Geriatr Cardiol"},{"issue":"1","key":"10.1016\/j.pharma.2016.05.001_bib0190","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1475-2891-14-6","article-title":"Role of homocysteine in the development of cardiovascular disease","volume":"14","author":"Ganguly","year":"2015","journal-title":"Nutr J"},{"issue":"15","key":"10.1016\/j.pharma.2016.05.001_bib0195","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1212\/WNL.0b013e3182a823cc","article-title":"Vitamin\u00a0B supplementation, homocysteine levels, and the risk of cerebrovascular disease: a meta-analysis","volume":"81","author":"Ji","year":"2013","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.pharma.2016.05.001_bib0100","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.clnu.2011.01.003","article-title":"Meta-analysis of B\u00a0vitamin supplementation on plasma homocysteine, cardiovascular and all-cause mortality","volume":"31","author":"Huang","year":"2012","journal-title":"Clin Nutr"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450916300207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450916300207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T23:32:23Z","timestamp":1757719943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450916300207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0003450916300207"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2016.05.001","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association entre syndrome m\u00e9tabolique et hyperhomocyst\u00e9in\u00e9mie dans une population alg\u00e9rienne","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2016.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}